Tech Company Financing Transactions
Network Bio Funding Round
Network Bio secured a $50 million financing round on 8/19/2026. Backers included Blue Venture Funds, Breyer Capital and Founders Fund.
Transaction Overview
Company Name
Announced On
8/19/2026
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to support the expansion of its life science platform, which develops disease-specific AI models trained on large scale tissue, blood, molecular, and clinical datasets.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
210 Longwood Avenue 4
Boston, MA 02115
USA
Boston, MA 02115
USA
Phone
Undisclosed
Website
Email Address
Overview
Network Bio is building generalizable AI models for human health and assembling the biological data needed to train them. These models create barcodes of health to accelerate disease detection, biomarker discovery and the development of more personalized therapies. The result is "General Medical Intelligence" that unlocks precision healthcare at scale, providing fast, accurate, quantitative answers about any disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Mike Pellini
Chief Executive Officer
Asad Ahmad
Chief Financial Officer
Ryan Jones
Chief Operating Officer
Mike Nall
Co-Founder
Hani Goodarzi
VP - Bus. Development
Raphael Potter
Browse more venture capital transactions:
Prev: 8/19/2026: Singular Photonics venture capital transaction
Next: 8/19/2026: Hypercubic venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs